FrancophonIA/ELRC3.0 huggingface dataset:
English: Uncommon side effects (may effect up to 1 in 100 people):
Icelandic: Sjaldgæfar aukaverkanir (geta komið fyrir hjá allt að 1 af hverjum 100 einstaklingum):
English: Long-term administration of buprenorphine during the last three months of pregnancy may cause a withdrawal syndrome in the neonate (e.g. hypertonia, neonatal tremor, neonatal agitation, myoclonus or convulsions).
Icelandic: Langtíma lyfjagjöf með búprenorfíni á síðustu þremur mánuðum meðgöngu getur framkallað fráhvarfsheilkenni hjá nýburanum (t.d. ofstælingu, nýburaskjálfta, nýburaæsing, vöðvakippi eða krampa).
English: 1.6-fold increase
Icelandic: 1,6 föld aukning
English: Abrupt discontinuation of treatment is not recommended as it may result in a withdrawal syndrome that may be delayed in onset.
Icelandic: Ekki er mælt með snöggri stöðvun meðferðar þar sem hún getur valdið fráhvarfsheilkenni, hugsanlega síðkomnu.
English: 2.7-fold increase
Icelandic: 2,7 föld aukning
English: After a satisfactory stabilisation has been achieved, if the patient agrees, the dosage may be reduced gradually to a lower maintenance dose; in some favourable cases, treatment may be discontinued.
Icelandic: Þegar sjúklingur er í viðunandi stöðugu ástandi má minnka skammtinn smám saman í minni viðhaldsskammt, ef sjúklingurinn fellst á það.
English: barbiturates (used to cause sleep or sedation) such as Phenobarbital, secobarbital tranquilisers (used to cause sleep or sedation) such as chloral hydrate.
Icelandic: Hı viðtakablokkar (notaðir til að meðhöndla ofnæmisviðbrögð) eins og diphenhydramín og chlorphenamín ­ Barbítúröt (notuð sem svefnlyf eða sem róandi lyf) eins og Phenobarbital, secobarbital.
English: Severe respiratory insufficiency
Icelandic: Alvarleg öndunarbilun
English: Buprenorphine and its metabolites are excreted in human breast milk.
Icelandic: Búprenorfín og umbrotsefni þess skiljast út í brjóstamjólk.
English: The recommended starting dose in adults and adolescents over 15 years of age is one to two Suboxone 2 mg/0.5 mg. An additional one to two Suboxone 2 mg/0.5 mg may be administered on day one depending on the individual patient's requirement.
Icelandic: Sá upphafsskammtur sem mælt er með hjá fullorðnum og unglingum yfir 15 ára aldri er ein til tvær töflur af Suboxone 2 mg/0,5 mg.
English: What Suboxone looks like and contents of the pack
Icelandic: Lýsing á útliti Suboxone og pakkningastærðir
English: Common side effects (may effect up to 1 in 10 people):
Icelandic: Algengar aukaverkanir (geta komið fyrir hjá allt að 1 af hverjum 10 einstaklingum):
English: Some risks of misuse and abuse include overdose, spread of blood borne viral or localised and systemic infections, respiratory depression and hepatic injury.
Icelandic: Hættur vegna misnotkunar og ofnotkunar eru meðal annars ofskömmtun, dreifing veirusýkinga sem berast með blóði eða staðbundnar og altækar sýkingar, öndunarbæling og lifrarskaði.
English: Suboxone 16 mg/4 mg sublingual tablets are white round biconvex tablets of 10.5 mm with “N16” debossed on one side.
Icelandic: Suboxone 16 mg/4 mg tungurótartöflur eru hvítar 10,5 mm kringlóttar, tvíkúptar töflur, ígreyptar með „N16“ á annarri hliðinni.
English: This product can cause withdrawal symptoms if you take it less than six hours after you use a short-acting opioid (e.g. morphine, heroin) or less than 24 hours after you use a long-acting opioid such as methadone.
Icelandic: eftir notkun ópíata með skammtímavirkni (t.d. morfín, heróín) eða innan 24 klst.
English: General warnings relevant to the administration of opioids Opioids may produce orthostatic hypotension in ambulatory patients.
Icelandic: Almenn varnaðarorð er tengjast gjöf ópíata Ópíöt geta framkallað réttstöðulágþrýsting hjá gangfærum sjúklingum.
English: o other central nervous system depressants, other opioid derivatives (e.g. methadone, analgesics and antitussives), certain antidepressants, sedative H1-receptor antagonists, barbiturates, anxiolytics other than benzodiazepines, neuroleptics, clonidine and related substances: these combinations increase central nervous system depression.
Icelandic: o Öðrum efnum sem hafa bælandi áhrif á miðtaugakerfið, öðrum ópíatafleiðum (t.d. metadón, verkjalyf og hóstastillandi lyf), vissum þunglyndislyfjum, slævandi H1-viðtakablokkum, barbitúrötum, kvíðastillandi lyfjum öðrum en benzódíazepínum, sefandi lyfjum, klónidíni og skyldum efnum:
English: Naloxone is an antagonist at -opioid receptors.
Icelandic: Naloxón er µ (mu) ópíat viðtaka blokki.
English: Dosage adjustment and maintenance therapy:
Icelandic: Stillling skammtastærðar og viðhaldsmeðferð:
English: Drug withdrawal syndrome neonatal (see section 4.6)
Icelandic: Fráhvarfs-heilkenni hjá nýburum (sjá kafla 4.6)
English: Clinical data confirm that CYP3A4 is responsible for the Ndealkylation of buprenorphine.
Icelandic: Klínískar niðurstöður staðfesta að N-afalkýlering búprenorfíns verði fyrir tilstilli CYP3A.
English: How to take Suboxone
Icelandic: Hvernig nota á Suboxone
English: In many cases the presence of pre-existing mitochondrial impairment (genetic disease, liver enzyme abnormalities, infection with hepatitis B or hepatitis C virus, alcohol abuse, anorexia concomitant use of other potentially hepatotoxic medicines) and ongoing injecting drug use may have a causative or contributory role.
Icelandic: Í mörgum tilvikum hefur skert starfsemi hvatbera verið til staðar (arfgengur sjúkdómur, óeðlileg ensímgildi í lifur, lifrarbólga B eða lifrarbólga C, áfengismisnotkun, lystarstol, samtímis notkun annarra lyfja sem geta haft eituráhrif á lifur) og notkun lyfja í bláæð sem geta haft áhrif eða stuðlað að þessum áhrifum.
English: • Starting treatment of Suboxone whilst dependent on heroin
Icelandic: Upphafsmeðferð með Suboxene við heróínfíkn
English: EU/1/06/359/004
Icelandic: EU/1/06/359/003 EU/1/06/359/004
English: Suboxone 8 mg/2 mg sublingual tablets are white hexagonal biconvex tablets of 11 mm with “N8” debossed on one side.
Icelandic: Suboxone 8 mg/2 mg tungurótartöflur eru hvítar 11 mm sexhyrndar, tvíkúptar töflur, ígreyptar með „N8“ á annarri hliðinni.
English: • recently suffered a head injury or brain disease
Icelandic: Nýlega höfuðáverka eða heilasjúkdóm
English: 1.2-fold increase
Icelandic: 1,2 föld aukning
English: EU/1/06/359/002
Icelandic: EU/1/06/359/001 EU/1/06/359/002
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Icelandic: SÉRSTAKAR VARÚÐARRÁÐSTAFANIR FYRIR FÖRGUN LYFJALEIFA EÐA ÚRGANGS VEGNA
English: Suboxone 2 mg/0.5 mg sublingual tablets are white hexagonal biconvex tablets of 6.5 mm with “N2” debossed on one side.
Icelandic: Suboxone 2 mg/0,5 mg tungurótartöflur eru hvítar 6,5 mm sexhyrndar, tvíkúptar töflur ígreyptar með, „N2“ á annarri hliðinni.
English: However, when administered intravenously to opioid-dependent persons, the presence of naloxone in Suboxone produces marked opioid antagonist effects and opioid withdrawal, thereby deterring intravenous abuse.
Icelandic: Þegar lyfið er gefið ópíat háðum einstaklingum í bláæð koma þó greinileg ópíat blokkandi áhrif og fráhvarfseinkenni í ljós vegna naloxóns sem er í Suboxone og kemur þannig í veg fyrir misnotkun með notkun í bláæð.
English: Buprenorphine/naloxone is contraindicated in patients with severe hepatic impairment (see section 4.3 and 5.2).
Icelandic: Ekki má nota búprenorfín/naloxón handa sjúklingum með alvarlega skerðingu á lifrarstarfsemi (sjá kafla 4.3 og 5.2).
English: Insomnia (inability to sleep), constipation, nausea, excessive sweating, headache, drug withdrawal syndrome
Icelandic: Svefnleysi, hægðatregða, ógleði, ofsvitnun, höfuðverkur, fráhvarfsheilkenni.
English: EU/1/06/359/006
Icelandic: EU/1/06/359/005 EU/1/06/359/006
English: 0.2-fold decrease
Icelandic: 0,2 föld aukning
English: • any liver disease such as hepatitis
Icelandic: Lifrarsjúkdóma eins og lifrarbólgu
English: Ongoing intravenous infusion rates should be titrated to patient response.
Icelandic: Áframhaldandi innrennsli í bláæð skal aðlagað að svörun sjúklings.
English: The recommended starting dose for adults and adolescents over the age of 15 years is one to two tablets of Suboxone 2 mg/0.5 mg. An additional one to two tablets of the Suboxone 2 mg/0.5 mg may be administered on day 1 depending on your needs.
Icelandic: Gefa má eina til tvær töflur af Suboxone 2 mg/0,5 mg til viðbótar á 1. degi eftir þörfum þínum.
English: Each 2 mg/0.5 mg sublingual tablet contains 2 mg buprenorphine (as hydrochloride) and 0.5 mg naloxone (as hydrochloride dihydrate).
Icelandic: Hver 2 mg/0,5 mg tungurótartafla inniheldur 2 mg búprenorfín (sem hýdróklóríð) og 0,5 mg naloxone (sem hýdróklóríð díhýdrat).
English: 3.2-fold increase
Icelandic: 3,2 föld aukning
English: Each 16 mg/4 mg sublingual tablet contains 16 mg buprenorphine (as hydrochloride) and 4 mg naloxone (as hydrochloride dihydrate).
Icelandic: Hver 16 mg/4 mg tungurótartafla inniheldur 16 mg búprenorfín (sem hýdróklóríð) og 4 mg naloxone (sem hýdróklóríð díhýdrat).
English: NAME OF THE MARKETING AUTHORISATION HOLDER Indivior Europe Limited
Icelandic: Ísland Indivior Europe Limited
English: Name and address of the manufacturer responsible for batch release Reckitt Benckiser Healthcare (UK) Ltd
Icelandic: Reckitt Benckiser Healthcare (UK) Ltd Dansom Lane
English: Sublingual tablet White round biconvex tablets of 10.5 mm with “N16” debossed on one side.
Icelandic: Tungurótartafla Hvítar kringlóttar, tvíkúptar 10,5 mm töflur, ígreyptar með „N16“ á annarri hliðinni.
English: Respiratory, thoracic and
Icelandic: Öndunarfæri, brjósthol og miðmæti
English: Taking Suboxone
Icelandic: Suboxone inniheldur
English: Sublingual tablet White hexagonal biconvex tablets of 11 mm with “N8” debossed on one side.
Icelandic: Tungurótartafla Hvítar sexhyrndar, tvíkúptar 11 mm töflur, ígreyptar með „N8“ á annarri hliðinni.
English: • Misuse and abuse
Icelandic: Misnotkun og ofnotkun
English: If you have the impression that the effect of Suboxone is too strong or too weak, talk to your doctor or pharmacist.
Icelandic: Leitaðu til læknisins eða lyfjafræðings ef þú telur að áhrif Suboxone séu of öflug eða of væg.
English: Buprenorphine/naloxone is contraindicated in patients with severe hepatic impairment.
Icelandic: Ekki má nota búprenorfín/naloxón hjá sjúklingum með alvarlega skerta lifrarstarfsemi.
English: Sublingual tablet White hexagonal biconvex tablets of 6.5 mm with “N2” debossed on one side.
Icelandic: Tungurótartafla Hvítar sexhyrndar, tvíkúptar 6,5 mm töflur, ígreyptar með „N2“ á annarri hliðinni.
English: Plasma levels of buprenorphine increased with the sublingual dose of buprenorphine/naloxone.
Icelandic: Plasmaþéttni búprenorfín eykst þegar Suboxone er gefið undir tungu.
English: o CYP3A4 inhibitors: an interaction study of buprenorphine with ketoconazole (a potent inhibitor of CYP3A4) resulted in increased Cmax and AUC (area under the curve) of buprenorphine (approximately 50 % and 70 % respectively) and, to a lesser extent, of norbuprenorphine.
Icelandic: Cmax um u.þ.b 50 % og AUC (flatarmál undir blóðþéttniferli) um u.þ.b. 70 % hjá búprenorfíni en í minna mæli hjá norbúprenorfíni.
English: Each 8 mg/2 mg tablet contains 8 mg buprenorphine (as hydrochloride) and 2 mg naloxone (as hydrochloride dihydrate).
Icelandic: Hver 8 mg/2 mg tungurótartafla inniheldur 8 mg búprenorfín (sem hýdróklóríð) og 2 mg naloxone (sem hýdróklóríð díhýdrat).
English: The first dose of Suboxone should be taken when signs of withdrawal appear, but not less than 24 hours after you last used methadone.
Icelandic: Taka skal fyrsta skammtinn af Suboxone þegar einkenni um fráhvarf hafa komið fram, en ekki fyrr en 24 klst.
English: EU/1/06/359/006 16 mg sublingual tablets 28
Icelandic: EU/1/06/359/005 16 mg tungurótartöflur 7 EU/1/06/359/006 16 mg tungurótartöflur 28
English: EU/1/06/359/002 2 mg sublingual tablets 28
Icelandic: EU/1/06/359/001 2 mg tungurótartöflur 7 EU/1/06/359/002 2 mg tungurótartöflur 28
English: Tell your doctor if you have any liver problems before you start treatment with Suboxone.
Icelandic: Áður en meðferð er hafin með Suboxone skaltu láta lækninn vita ef þú átt við lifrarsjúkdóma að stríða.
English: Pharmacotherapeutic group: Other nervous system drugs, drugs used in addictive disorders, ATC code: N07BC51.
Icelandic: Önnur lyf með verkun á taugakerfið, lyf gegn ópíatfíkn, ATC flokkur:
English: EU/1/06/359/004 8 mg sublingual tablets 28
Icelandic: EU/1/06/359/003 8 mg tungurótartöflur 7 EU/1/06/359/004 8 mg tungurótartöflur 28
English: Depersonalisation Drug dependence Euphoric mood Hostility
Icelandic: Sinnuleysi Sjálfshvarf (depersonalization) Lyfjafíkn
English: INFORMATION IN BRAILLE Suboxone 16 mg/4 mg sublingual tablets
Icelandic: Upplýsingar fyrir notanda lyfsins Suboxone 16 mg/4 mg tungurótartöflur
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS PACK OF 7 and 28 TABLETS 2 mg STRENGTH
Icelandic: LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á ÞYNNUM EÐA STRIMLUM PAKKNING MEÐ 7 og 28 TÖFLUM 2 mg AÐ STYRKLEIKA
English: Asthma Dyspnoea
Icelandic: Astmi Andnauð Geispi
English: NAME OF THE MEDICINAL PRODUCT Suboxone 16 mg/4 mg sublingual tablets buprenorphine/naloxone
Icelandic: Suboxone 16 mg/4 mg tungurótartöflur búprenorfín/naloxón
English: AUTHORISATION
Icelandic: Ofsvitnun
English: INFORMATION IN BRAILLE Suboxone 8 mg/2 mg sublingual tablets
Icelandic: Upplýsingar fyrir notanda lyfsins Suboxone 8 mg/2 mg tungurótartöflur
English: • Blood pressure
Icelandic: Blóðfituhækkun
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS PACK OF 7 and 28 TABLETS 8 mg STRENGTH
Icelandic: LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á ÞYNNUM EÐA STRIMLUM PAKKNING MEÐ 7 og 28 TÖFLUM 8 mg AÐ STYRKLEIKA
English: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to special and restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Icelandic: VIÐAUKI II A. FRAMLEIÐENDUR SEM ERU ÁBYRGIR FYRIR LOKASAMÞYKKT B. FORSENDUR FYRIR, EÐA TAKMARKANIR Á, AFGREIÐSLU OG NOTKUN C. AÐRAR FORSENDUR OG SKILYRÐI MARKAÐSLEYFIS D. FORSENDUR EÐA TAKMARKANIR ER VARÐA ÖRYGGI OG VERKUN VIÐ NOTKUN LYFSINS
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACK OF 7 and 28 TABLETS 16 mg STRENGTH
Icelandic: UPPLÝSINGAR SEM EIGA AÐ KOMA FRAM Á YTRI UMBÚÐUM PAKKNING MEÐ 7 og 28 TÖFLUM 16 mg AÐ STYRKLEIKA
English: Opioid agonist ceiling effects were observed during clinical pharmacology studies in opioid-dependent persons.
Icelandic: Þak örvandi áhrifa ópíata komu í ljós meðan á klínískum lyfjafræðirannsóknum á ópíatfíklum stóð.
English: Each sublingual tablet contains 2 mg buprenorphine (as hydrochloride) and 0.5 mg naloxone (as hydrochloride dihydrate).
Icelandic: Hver tungurótartafla inniheldur 2 mg búprenorfín (sem hýdróklóríð) og 0,5 mg naloxón (sem hýdróklóríð díhýdrat).
English: INFORMATION IN BRAILLE Suboxone 2 mg/0.5 mg sublingual tablets
Icelandic: Upplýsingar fyrir notanda lyfsins Suboxone 2 mg/0,5 mg tungurótartöflur
English: If you take more Suboxone than you should
Icelandic: Ef tekinn er stærri skammtur en mælt er fyrir um
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACK OF 7 and 28 TABLETS 2 mg STRENGTH
Icelandic: UPPLÝSINGAR SEM EIGA AÐ KOMA FRAM Á YTRI UMBÚÐUM PAKKNING MEÐ 7 og 28 TÖFLUM 2 mg AÐ STYRKLEIKA
English: Clinical data confirm that CYP3A4 is responsible for the N
Icelandic: o CYP3A4 örvar:
English: Weight loss, swelling (hands and feet), drowsiness, anxiety, nervousness, tingling, depression, decreased sexual drive, increase in muscle tension, abnormal thinking, increased tearing (watering eyes) or other tearing disorder, blurred vision, flushing, increased blood pressure, migraines, runny nose, sore throat and painful swallowing, increased cough, upset stomach or other stomach discomfort, diarrhoea, abnormal liver function, flatulence, vomiting, rash, itching, hives, pain, joint pain, muscle pain, leg cramps (muscle spasm), difficulty in getting or keeping an erection, urine abnormality, abdominal pain, back pain, weakness, infection, chills, chest pain, fever, flu-like symptoms, feeling of general discomfort, accidental injury caused by loss of alertness or co-ordination, faintness and dizziness.
Icelandic: Þyngdartap, bólga (handa og fóta), syfja, kvíði, órói, náladofi, þunglyndi, minnkuð kynhvöt, aukin vöðvaspenna, óeðlilegar hugsanir, aukin tárumyndun (vökvi í augum) eða annar tárakvilli, óskýr sjón, andlitsroði, hækkaður blóðþrýstingur, mígreni, nefrennsli, hálsbólga og erfiðleikar við kyngingu, aukinn hósti, magaórói eða önnur magaóþægindi, niðurgangur, óeðlileg lifrarstarfsemi, vindgangur, uppköst, útbrot, kláði, ofsakláði, sársauki, liðverkir, vöðvaverkir, sinadráttur í fótleggjum, risvandamál, þvagrásarvandamál, kviðverkir, bakverkir, slappleiki, sýking, hrollur, brjóstverkur, hiti, flensulík einkenni, almenn vanlíðan, áverki fyrir slysni vegna minnkaðar árverkni eða ósamhæfingar, svimi og sundl.
English: Patients requiring a titrated daily dose> 8 mg buprenorphine/day may not find this regimen adequate.
Icelandic: Ekki er víst að þetta sé nægjanlegt hjá sjúklingum sem hafa verið stilltir á dagskammt > 8 mg/dag af búprenorfíni.
English: Its activity in opioid maintenance treatment is attributed to its slowly reversible properties with the -opioid receptors which, over a prolonged period, might minimise the need of addicted patients for drugs.
Icelandic: Virkni þess í ópíata viðhaldsmeðferð má rekja til hægrar, afturkræfrar tengingar við µ-viðtaka, sem getur hugsanlega dregið úr lyfjafíkn sjúklingsins, þegar til lengri tíma er litið.
English: 1.1-fold Increase
Icelandic: 1,1 föld aukning
English: Each sublingual tablet contains 16 mg buprenorphine (as hydrochloride) and 4 mg naloxone (as hydrochloride dihydrate).
Icelandic: Hver tungurótartafla inniheldur 16 mg búprenorfín (sem hýdróklóríð) og 4 mg naloxón (sem hýdróklóríð díhýdrat).
English: • Starting treatment of Suboxone whilst dependent on methadone
Icelandic: Upphafsmeðferð með Suboxen við metadónfíkn
English: Anxiety Depression Libido decreased Nervousness Thinking abnormal
Icelandic: Kvíði Þunglyndi Minnkuð kynhvöt Órói
English: Musculoskeletal and connective tissue disorders
Icelandic: Náttúruleg sítrónu- og límónubragðefni
English: Each sublingual tablet contains 8 mg buprenorphine (as hydrochloride) and 2 mg naloxone (as hydrochloride dihydrate).
Icelandic: Hver tungurótartafla inniheldur 8 mg búprenorfín (sem hýdróklóríð) og 2 mg naloxón (sem hýdróklóríð díhýdrat).
English: The spectrum of abnormalities ranges from transient asymptomatic elevations in hepatic transaminases to case reports of hepatic failure, hepatic necrosis, hepatorenal syndrome, hepatic encephalopathy and death.
Icelandic: Um er að ræða óeðlileg gildi sem eru allt frá tímabundinni hækkun á lifrartransamínösum til lifrarbilunar, lifrardreps, lifrar- og nýrnaheilkenna, lifrarheilakvilla (hepatic encephalopathy) og dauða.
English: When taken during pregnancy, particularly late pregnancy, medicines like Suboxone may cause drug withdrawal symptoms including problems with breathing in your newborn baby.
Icelandic: Við inntöku lyfja eins og Suboxone á meðan meðgöngu stendur, sér í lagi á síðari hluta meðgöngu, getur slíkt valdið fráhvarfseinkennum ásamt öndunarerfiðleikum hjá nýburanum.
English: Dansom Lane
Icelandic: HEITI LYFS
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACK OF 7 and 28 TABLETS 8 mg STRENGTH
Icelandic: UPPLÝSINGAR SEM EIGA AÐ KOMA FRAM Á YTRI UMBÚÐUM PAKKNING MEÐ 7 og 28 TÖFLUM 8 mg AÐ STYRKLEIKA
English: Abdominal Pain
Icelandic: Mígreni Sundl
English: Do not take any other medicines whilst taking Suboxone without first talking to your doctor especially:
Icelandic: Suboxone er notað á þess að ráðfæra þig við lækninn fyrst, sér í lagi eftirfarandi lyf:
English: HU8 7DS
Icelandic: AUC0-48
English: Store the blister safely.
Icelandic: Geymið þynnuna á öruggum stað.
English: NAME OF THE MEDICINAL PRODUCT Suboxone 2 mg/0.5 mg sublingual tablets buprenorphine/naloxone
Icelandic: Suboxone 2 mg/0,5 mg tungurótartöflur búprenorfín/naloxón
English: NAME OF THE MEDICINAL PRODUCT Suboxone 2 mg/0.5 mg sublingual tablets buprenorphine / naloxone
Icelandic: Suboxone 2 mg/0,5 mg tungurótartöflur Búprenorfín/naloxón
English: NAME OF THE MEDICINAL PRODUCT Suboxone 8 mg/2 mg sublingual tablets buprenorphine/naloxone
Icelandic: Suboxone 8 mg/2 mg tungurótartöflur búprenorfín / naloxón
English: NAME OF THE MEDICINAL PRODUCT Suboxone 8 mg/2 mg sublingual tablets buprenorphine / naloxone
Icelandic: Suboxone 8 mg/2 mg tungurótartöflur búprenorfín/naloxón
English: Asthma Dyspnoea Yawning
Icelandic: Búprenorfín/naloxón
English: Swollen glands (lymph nodes), agitation, tremor, abnormal dream, excessive muscle activity, depersonalisation (not feeling like yourself), medicine dependence, amnesia (memory disturbance), loss of interest, exaggerated feeling of well-being, convulsion (fits), speech disorder, small pupil size, difficulty urinating, eye inflammation or infection, rapid or slow heartbeat, low blood pressure, palpitations, myocardial infarction (heart attack), chest tightness, shortness of breath, asthma, yawning, pain and sores in mouth, tongue discolouration, acne, skin nodule, hair loss, dry or scaling skin, inflammation of joints, urinary tract infection, abnormal blood tests, blood in urine, abnormal ejaculation, menstrual or vaginal problems, kidney stone, protein in your urine, painful or difficult urination, sensitivity to heat or cold, heat stroke, loss of appetite, feelings of hostility.
Icelandic: Bólgnir eitlar, órói, skjálfti, óeðlilegir draumar, ofvirkni vöðva, að finnast maður ekki vera maður sjálfur (sjálfshvarf), lyfjafíkn, minnistap, áhugaleysi, sælutilfinning, krampar, taltruflanir, minnkuð stærð augasteins, erfiðleikar við þvaglát, sýking eða bólga í augum, hraður eða hægur hjartsláttur, lágur blóðþrýstingur, hjartsláttaróregla, hjartaáfall, þrengsli í brjósti, mæði, astmi, geispi, sársauki og munnangur, aflitun tungu, bólur, húðhnúður, hárlos, þurr eða flögnuð húð, liðbólga, þvagfærasýking, óeðlileg niðurstaða blóðprufu, blóð í þvagi, óeðlilegt sáðlát, vandamál með tíðahring og legháls, nýrnasteinar, prótín í þvagi, sársaukafull eða erfið þvaglát, viðkvæmni fyrir hita eða kulda, hitaslag, lystarleysi, óvild.
English: Albuminuria Dysuria
Icelandic: Meltingartrufla nir
English: Lactose monohydrate Mannitol
Icelandic: Laktósi mónóhýdrat Mannitól
English: Constipation Nausea
Icelandic: Minnkuð matarlyst
English: • thyroid problems
Icelandic: Skjaldkirtilsvandamál
English: PHARMACEUTICAL FORM AND CONTENTS 7 sublingual tablets
Icelandic: Notkun annarra lyfja samhliða Suboxone
English: Abdominal Pain Diarrhoea Dyspepsia Flatulence
Icelandic: Fráhvarfs-heilkenni Slen Brjóstverkur
English: Cough
Icelandic: Skalli
English: 28 sublingual tablets
Icelandic: 7 tungurótartöflur 28 tungurótartöflur
English: Vomiting
Icelandic: Ofkæling
English: What you need to know before you take Suboxone
Icelandic: Áður en byrjað er að nota Suboxone Ekki má taka Suboxone
English: • Other medicines that may make you feel sleepy which are used to treat illnesses such as anxiety, sleeplessness, convulsions/seizures, pain.
Icelandic: • Önnur lyf sem geta hugsanlega valdið syfju sem eru notuð við kvillum eins og kvíða,
English: Oedema peripheral
Icelandic: Bjúgur í útlimum
English: Bronchospasm Respiratory depression
Icelandic: Þunglyndi Minnkuð kynhvöt Órói
English: other opioid containing medicines such as methadone, certain pain killers and cough suppressants anti-depressants (used to treat depression) such as isocarboxazid, phenelzine, selegiline, tranylcypromine and valproate may increase the effects of this medicine.
Icelandic: ­ Þunglyndislyf (notuð til að meðhöndla þunglyndi) eins og isocarboxazíð, phenelzín, selegilín,
English: Amnesia Hyperkinesia Sezuire
Icelandic: Sítrónusýra, vatnsfrí Natríumsítrat
English: Baseline liver function tests and documentation of viral hepatitis status is recommended prior to commencing therapy.
Icelandic: Áður en meðferð hefst er mælt með að gera lifrarpróf og kanna ástand lifrar með tilliti til lifrarbólgu af völdum veirusýkinga.
English: MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration
Icelandic: (Sér)heiti Styrkleiki Lyfjaform